The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy

Diabetologia

Volumn 58, Issue 4, 2015, Pages 666-677

  Østergaard, Leif ^a   Finnerup, Nanna B ^b   Terkelsen, Astrid J ^a,b   Olesen, Rasmus A ^a   Drasbek, Kim R ^a   Knudsen, Lone ^b,c   Jespersen, Sune N ^a,b   Frystyk, Jan ^a   Charles, Morten ^a   Thomsen, Reimar W ^b   Christiansen, Jens S ^a   Beck Nielsen, Henning ^d,e   Jensen, Troels S ^a,b   Andersen, Henning ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c VIBORG HOSPITAL   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Capillary dysfunction; Diabetic complications; Diabetic neuropathy; Glucose intolerance; Glucose transport; Microvascular disease

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALDEHYDE REDUCTASE; GLUCOSE; OXYGEN; GLUCOSE BLOOD LEVEL;

BLOOD VESSEL REACTIVITY; CAPILLARY DYSFUNCTION; CAPILLARY FLOW; DIABETIC NEUROPATHY; ENZYME ACTIVITY; EXPERIMENTAL DIABETES MELLITUS; HUMAN; HYPERGLYCEMIA; HYPOXIA; INSULIN DEPENDENT DIABETES MELLITUS; NERVE CONDUCTION; NERVE FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; OXYGEN TISSUE LEVEL; PAIN; PRIORITY JOURNAL; REVIEW; TISSUE BLOOD FLOW; TISSUE OXYGENATION; TISSUE PERFUSION; VASCULAR DISEASE; ANIMAL; BLOOD; BLOOD FLOW; BLOOD FLOW VELOCITY; CAPILLARY; CELL HYPOXIA; DIABETIC NEUROPATHIES; GLUCOSE BLOOD LEVEL; METABOLISM; MICROCIRCULATION; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PERIPHERAL NERVE; VASCULARIZATION;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD GLUCOSE; CAPILLARIES; CELL HYPOXIA; DIABETIC NEUROPATHIES; HUMANS; MICROCIRCULATION; OXYGEN; OXYGEN CONSUMPTION; PERIPHERAL NERVES; REGIONAL BLOOD FLOW;

EID: 84925467087     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3461-z     Document Type: Review

References (106)

1. Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL (2012) Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 11:521–534
2. Peltier A, Goutman SA, Callaghan BC (2014) Painful diabetic neuropathy. BMJ 348:g1799
3. Tesfaye S, Selvarajah D (2012) Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev 28(Suppl 1):8–14
4. Giannini C, Dyck PJ (1995) Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity. Ann Neurol 37:498–504
5. Thrainsdottir S, Malik RA, Dahlin LB et al (2003) Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man. Diabetes 52:2615–2622
6. Cameron NE, Eaton SE, Cotter MA, Tesfaye S (2001) Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 44:1973–1988
7. Tuck RR, Schmelzer JD, Low PA (1984) Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107:935–950
8. Jaap AJ, Hammersley MS, Shore AC, Tooke JE (1994) Reduced microvascular hyperaemia in subjects at risk of developing type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 37:214–216
9. Tilton RG, Chang K, Hasan KS et al (1993) Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42:221–232
10. Tilton RG, Chang K, Nyengaard JR, van den Enden M, Ido Y, Williamson JR (1995) Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats. Diabetes 44:234–242
11. Theriault M, Dort J, Sutherland G, Zochodne DW (1997) Local human sural nerve blood flow in diabetic and other polyneuropathies. Brain 120:1131–1138
12. Vincent AM, Calabek B, Roberts L, Feldman EL (2013) Biology of diabetic neuropathy. Handb Clin Neurol 115:591–606
13. Jespersen SN, Østergaard L (2012) The roles of cerebral blood flow, capillary transit time heterogeneity and oxygen tension in brain oxygenation and metabolism. J Cereb Blood Flow Metab 32:264–277
14. Østergaard L, Tietze A, Nielsen T et al (2013) The relationship between tumor blood flow, angiogenesis, tumor hypoxia, and aerobic glycolysis. Cancer Res 73:5618–5624
15. Østergaard L, Aamand R, Gutierrez-Jimenez E et al (2013) The capillary dysfunction hypothesis of Alzheimer's disease. Neurobiol Aging 34:1018–1031
16. Low PA, Lagerlund TD, McManis PG (1989) Nerve blood flow and oxygen delivery in normal, diabetic, and ischemic neuropathy. Int Rev Neurobiol 31:355–438
17. Coppey LJ, Davidson EP, Dunlap JA, Lund DD, Yorek MA (2000) Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve. Int J Exp Diabetes Res 1:131–143
18. Zochodne DW, Ho LT (1992) Normal blood flow but lower oxygen tension in diabetes of young rats: microenvironment and the influence of sympathectomy. Can J Physiol Pharmacol 70:651–659
19. Obrosova IG, Drel VR, Oltman CL et al (2007) Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. Am J Physiol Endocrinol Metab 293:E1645–E1655
20. Yemisci M, Gursoy-Ozdemir Y, Vural A, Can A, Topalkara K, Dalkara T (2009) Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med 15:1031–1037
21. Haefliger IO, Zschauer A, Anderson DR (1994) Relaxation of retinal pericyte contractile tone through the nitric oxide-cyclic guanosine monophosphate pathway. Invest Ophthalmol Vis Sci 35:991–997
22. Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK (1994) Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia 37:449–459
23. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Yorek MA (2001) Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 50:1927–1937
24. Tesfaye S, Harris N, Jakubowski JJ et al (1993) Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 36:1266–1274
25. Eltzschig HK, Carmeliet P (2011) Hypoxia and inflammation. N Engl J Med 364:656–665
26. Toth C, Rong LL, Yang C et al (2008) Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy. Diabetes 57:1002–1017
27. Kallestrup M, Moller HJ, Tankisi H, Andersen H (2014) Soluble CD163 levels are elevated in cerebrospinal fluid and serum in people with type 2 diabetes mellitus and are associated with impaired peripheral nerve function. Diabet Med. doi:10.1111/dme.12568
28. Yuan G, Khan SA, Luo W, Nanduri J, Semenza GL, Prabhakar NR (2011) Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia. J Cell Physiol 226:2925–2933
29. Pop-Busui R, Sima A, Stevens M (2006) Diabetic neuropathy and oxidative stress. Diabetes Metab Res Rev 22:257–273
30. Hafer-Macko CE, Ivey FM, Sorkin JD, Macko RF (2007) Microvascular tissue plasminogen activator is reduced in diabetic neuropathy. Neurology 69:268–274
31. Teng HK, Teng KK, Lee R et al (2005) ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci 25:5455–5463
32. Andreassen CS, Jakobsen J, Flyvbjerg A, Andersen H (2009) Expression of neurotrophic factors in diabetic muscle–relation to neuropathy and muscle strength. Brain 132:2724–2733
33. Ali TK, Matragoon S, Pillai BA, Liou GI, El-Remessy AB (2008) Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes. Diabetes 57:889–898
34. Richner M, Ulrichsen M, Elmegaard SL, Dieu R, Pallesen LT, Vaegter CB (2014) Peripheral nerve injury modulates neurotrophin signaling in the peripheral and central nervous system. Mol Neurobiol 50:945–970
35. Ibrahim S, Harris ND, Radatz M et al (1999) A new minimally invasive technique to show nerve ischaemia in diabetic neuropathy. Diabetologia 42:737–742
36. Young MJ, Veves A, Walker MG, Boulton AJ (1992) Correlations between nerve function and tissue oxygenation in diabetic patients: further clues to the aetiology of diabetic neuropathy? Diabetologia 35:1146–1150
37. Tesfaye S, Malik R, Harris N et al (1996) Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 39:329–335
38. Armulik A, Abramsson A, Betsholtz C (2005) Endothelial/pericyte interactions. Circ Res 97:512–523
39. Greene DA, Winegrad AI (1979) In vitro studies of the substrates for energy production and the effects of insulin on glucose utilization in the neural components of peripheral nerve. Diabetes 28:878–887
40. Rechthand E, Smith QR, Rapoport SI (1989) Structural specificity of sugar transport at the blood-nerve barrier. J Neurochem 53:119–123
41. Muona P, Jaakkola S, Salonen V, Peltonen J (1993) Expression of glucose transporter 1 in adult and developing human peripheral nerve. Diabetologia 36:133–140
42. Knudsen GM, Pettigrew KD, Paulson OB, Hertz MM, Patlak CS (1990) Kinetic analysis of blood-brain barrier transport of d-glucose in man: quantitative evaluation in the presence of tracer backflux and capillary heterogeneity. Microvasc Res 39:28–49
43. Poduslo JF, Curran GL (1992) Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy. Proc Natl Acad Sci U S A 89:2218–2222
44. Cameron NE, Cotter MA, Basso M, Hohman TC (1997) Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 40:271–281
45. Obrosova IG, Fathallah L, Lang HJ, Greene DA (1999) Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study. Diabetologia 42:1187–1194
46. Schmidt RE, Dorsey DA, Beaudet LN et al (2005) A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetes. Exp Neurol 192:407–419
47. Sytze van Dam P, Cotter MA, Bravenboer B, Cameron NE (2013) Pathogenesis of diabetic neuropathy: focus on neurovascular mechanisms. Eur J Pharmacol 719:180–186
48. Hotta N, Akanuma Y, Kawamori R et al (2006) Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial. Diabetes Care 29:1538–1544
49. Bril V, Hirose T, Tomioka S, Buchanan R, Ranirestat Study Group (2009) Ranirestat for the management of diabetic sensorimotor polyneuropathy. Diabetes Care 32:1256–1260
50. Nieuwdorp M, Mooij HL, Kroon J et al (2006) Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 55:1127–1132
51. Vink H, Constantinescu AA, Spaan JA (2000) Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation 101:1500–1502
52. Constantinescu AA, Vink H, Spaan JA (2001) Elevated capillary tube hematocrit reflects degradation of endothelial cell glycocalyx by oxidized LDL. Am J Physiol Heart Circ Physiol 280:H1051–H1057
53. Vink H, Duling BR (1996) Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res 79:581–589
54. Secomb TW, Hsu R, Pries AR (1998) A model for red blood cell motion in glycocalyx-lined capillaries. Am J Physiol 274:H1016–H1022
55. Vincent AM, Hayes JM, McLean LL, Vivekanandan-Giri A, Pennathur S, Feldman EL (2009) Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. Diabetes 58:2376–2385
56. Mattson MP, Meffert MK (2006) Roles for NF-κB in nerve cell survival, plasticity, and disease. Cell Death Differ 13:852–860
57. Tegeder I, Niederberger E, Schmidt R et al (2004) Specific inhibition of IκB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J Neurosci 24:1637–1645
58. Berti-Mattera LN, Kern TS, Siegel RE, Nemet I, Mitchell R (2008) Sulfasalazine blocks the development of tactile allodynia in diabetic rats. Diabetes 57:2801–2808
59. Østergaard L, Terkelsen AJ, Finnerup NB et al (2014) Capillary dysfunction and impaired tissue oxygenation in complex regional pain syndrome: a hypothesis. Pain 155:1922–1926
60. Watkins PJ, Edmonds ME (1983) Sympathetic nerve failure in diabetes. Diabetologia 25:73–77
61. Gabbay IE, Gabbay M, Gabbay U (2014) Diabetic foot cellular hypoxia may be due to capillary shunting–a novel hypothesis. Med Hypotheses 82:57–59
62. Archer AG, Roberts VC, Watkins PJ (1984) Blood flow patterns in painful diabetic neuropathy. Diabetologia 27:563–567
63. Kobayashi T, Puro DG (2007) Loss of insulin-mediated vasoprotection: early effect of diabetes on pericyte-containing microvessels of the retina. Invest Ophthalmol Vis Sci 48:2350–2355
64. Geraldes P, Hiraoka-Yamamoto J, Matsumoto M et al (2009) Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med 15:1298–1306
65. Peppiatt CM, Howarth C, Mobbs P, Attwell D (2006) Bidirectional control of CNS capillary diameter by pericytes. Nature 443:700–704
66. Hall CN, Reynell C, Gesslein B et al (2014) Capillary pericytes regulate cerebral blood flow in health and disease. Nature 508:55–60
67. Kawamura H, Sugiyama T, Wu DM et al (2003) ATP: a vasoactive signal in the pericyte-containing microvasculature of the rat retina. J Physiol 551:787–799
68. Yamanishi S, Katsumura K, Kobayashi T, Puro DG (2006) Extracellular lactate as a dynamic vasoactive signal in the rat retinal microvasculature. Am J Physiol Heart Circ Physiol 290:H925–H934
69. Puro DG (2007) Physiology and pathobiology of the pericyte-containing retinal microvasculature: new developments. Microcirculation 14:1–10
70. Siperstein MD, Unger RH, Madison LL (1968) Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. J Clin Invest 47:1973–1999
71. Reske-Nielsen E, Lundbaek K, Rafaelsen OJ (1966) Pathological changes in the central and peripheral nervous system of young long-term diabetics: I. Diabetic encephalopathy. Diabetologia 1:233–241
72. Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA (2010) Glial and neuronal control of brain blood flow. Nature 468:232–243
73. Kawamura H, Kobayashi M, Li Q et al (2004) Effects of angiotensin II on the pericyte-containing microvasculature of the rat retina. J Physiol 561:671–683
74. Schonfelder U, Hofer A, Paul M, Funk RH (1998) In situ observation of living pericytes in rat retinal capillaries. Microvasc Res 56:22–29
75. Diaz-Flores L, Gutierrez R, Madrid JF et al (2009) Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 24:909–969
76. Lundberg JO, Weitzberg E, Gladwin MT (2008) The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 7:156–167
77. Carter P, Gray LJ, Troughton J, Khunti K, Davies MJ (2010) Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ 341:c4229
78. Yuen KC, Baker NR, Rayman G (2002) Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study. Diabetes Care 25:1699–1703
79. Malik RA, Williamson S, Abbott C et al (1998) Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet 352:1978–1981
80. Coppey LJ, Davidson EP, Rinehart TW et al (2006) ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats. Diabetes 55:341–348
81. Manschot SM, Gispen WH, Kappelle LJ, Biessels GJ (2003) Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor. Diabetes Metab Res Rev 19:469–477
82. Kappelle AC, Biessels GJ, van Buren T, Erkelens DW, de Wildt DJ, Gispen WH (1993) Effects of nimodipine on sciatic nerve blood flow and vasa nervorum responsiveness in the diabetic rat. Eur J Pharmacol 250:43–49
83. 2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat. Br J Pharmacol 111:887–893
84. Martin CL, Albers JW, Pop-Busui R, DCCT/EDIC Research Group (2014) Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care 37:31–38
85. Hernandez N, Torres SH, Finol HJ, Vera O (1999) Capillary changes in skeletal muscle of patients with essential hypertension. Anat Rec 256:425–432
86. Corvera S, Gealekman O (2014) Adipose tissue angiogenesis: impact on obesity and type-2 diabetes. Biochim Biophys Acta 1842:463–472
87. Asghar O, Petropoulos IN, Alam U et al (2014) Corneal confocal microscopy detects neuropathy in subjects with impaired glucose tolerance. Diabetes Care 37:2643–2646
88. Ziegler D, Papanas N, Zhivov A et al (2014) Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes 63:2454–2463
89. Capone C, Faraco G, Park L, Cao X, Davisson RL, Iadecola C (2011) The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension. Am J Physiol Heart Circ Physiol 300:H397–H407
90. Mazzoni MC, Schmid-Schonbein GW (1996) Mechanisms and consequences of cell activation in the microcirculation. Cardiovasc Res 32:709–719
91. Barnes AJ, Locke P, Scudder PR, Dormandy TL, Dormandy JA, Slack J (1977) Is hyperviscosity a treatable component of diabetic microcirculatory disease? Lancet 2:789–791
92. Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL (2009) Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 58:1634–1640
93. Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP (2013) The role of statins in the treatment of type 2 diabetes mellitus: an update. Curr Pharm Des 20:3665–3674
94. Davis TM, Yeap BB, Davis WA, Bruce DG (2008) Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 51:562–566
95. Nielsen SF, Nordestgaard BG (2014) Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study. Lancet Diabetes Endocrinol 2:894–900
96. Ii M, Nishimura H, Kusano KF et al (2005) Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy. Circulation 112:93–102
97. Malik RA, Tesfaye S, Ziegler D (2013) Medical strategies to reduce amputation in patients with type 2 diabetes. Diabet Med 30:893–900
98. Albaugh G, Bellavance E, Strande L, Heinburger S, Hewitt CW, Alexander JB (2004) Nicotine induces mononuclear leukocyte adhesion and expression of adhesion molecules, VCAM and ICAM, in endothelial cells in vitro. Ann Vasc Surg 18:302–307
99. Yong T, Zheng MQ, Linthicum DS (1997) Nicotine induces leukocyte rolling and adhesion in the cerebral microcirculation of the mouse. J Neuroimmunol 80:158–164
100. Tesfaye S, Chaturvedi N, Eaton SE et al (2005) Vascular risk factors and diabetic neuropathy. N Engl J Med 352:341–350
101. Nappo F, de Rosa N, Marfella R et al (1999) Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA 281:2113–2118
102. Ambrosch A, Dierkes J, Lobmann R et al (2001) Relation between homocysteinaemia and diabetic neuropathy in patients with type 2 diabetes mellitus. Diabet Med 18:185–192
103. Wile DJ, Toth C (2010) Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy. Diabetes Care 33:156–161
104. Lee J, Wu W, Jiang JY, Zhu B, Boas DA (2012) Dynamic light scattering optical coherence tomography. Opt Express 20:22262–22277
105. Sakadzic S, Roussakis E, Yaseen MA et al (2010) Two-photon high-resolution measurement of partial pressure of oxygen in cerebral vasculature and tissue. Nat Methods 7:755–759
106. Mouridsen K, Hansen MB, Østergaard L, Jespersen SN (2014) Reliable estimation of capillary transit time distributions using DSC-MRI. J Cereb Blood Flow Metab 34:1511–1521